The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., ... & Nemeroff, C. B. | Jama psychiatry | 1 April 2017
The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
Abdallah, C. G., Jackowski, A., Salas, R., Gupta, S., Sato, J. R., Mao, X., ... & Mathew, S. J. | Neuropsychopharmacology | 8 March 2017
Ketamine for Treatment-Resistant Depression
Mathew, S. J., & Zarate Jr, C. A. | Springer International Publishing | 1 December 2016
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches
Al Jurdi, R. K., Swann, A., & Mathew, S. J. | Current psychiatry reports | 1 August 2015
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
Murrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., ... & Iosifescu, D. V. | Translational psychiatry | 17 February 2015
Therapeutic infusions of ketamine: Do the psychoactive effects matter?
Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., & Nunes, E. V. | Drug and alcohol dependence | 18 Feb 2014